Search Results 1141-1150 of 18135 for monoclonal antibody

  1. Cancer blood tests: Lab tests used in cancer diagnosis - Mayo Clinic

    ... Medical marijuana · Monoclonal antibody medicines for cancer: How they work · Mouth sores caused by cancer treatment: How to cope · MRI · Needle biopsy.

  2. A Study Evaluating The Effectiveness And Safety Of Axicabtagene Ciloleucel In Subjects With High-Risk Large B-Cell Lymphoma - Mayo Clinic

    2 cycles of an anti-CD20 monoclonal antibody (unless investigator determines that tumor is CD20 negative) and anthracycline-containing regimen (e.g., DA ...

  3. AHEAD 3-45 Study - Mayo Clinic

    Hypersensitivity to any monoclonal antibody treatment 7. Any immunological disease which is not adequately controlled, or which requires treatment with ...

  4. Gary A. Croghan, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    1983. PhD - General Experimental Pathology Dissertation: An Epithelial and Tumor-Associated Antigen Recognized by Monoclonal Antibody F36/22State University of ...

  5. Cancer treatment - Doctors & Departments - Mayo Clinic

    Monoclonal antibody medicines for cancer: How they work · Mouth sores caused by cancer treatment: How to cope · Multiple myeloma · Myxofibrosarcoma ...

  6. Medical Research & Education - Mayo Clinic News Network

    Antibody-drug conjugates are targeted cancer therapies. They deliver potent drugs directly into cancer cells while minimizing harm to healthy tissue. These ...

  7. Clinical trials - Oncology (Medical)

    Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...

  8. A Study Of JNJ-68284528, A Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) In Participants With Multiple Myeloma - Mayo Clinic

    Previously treated with a PI, an IMiD, an anti-CD38 monoclonal antibody and B-cell maturation antigen (BCMA)-directed therapy. Cohort D: Newly diagnosed ...

  9. Overview - Transplant Immunology Program - Mayo Clinic Research

    The Transplant Immunology Program at Mayo Clinic is overcoming antibody-related organ rejection, improving long-term outcomes and forging key partnerships.

  10. Study Of Pembrolizumab (MK-3475) In Participants With Relapsed Or Refractory Primary Mediastinal Large B-cell Lymphoma Or Relapsed Or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) - Mayo Clinic

    Prior monoclonal antibody within 4 weeks prior to study Day 1 (2 weeks for RS participants) or who has not recovered (i.e. ≤ Grade 1 or at baseline) from ...